Exabis Library
Welcome to the e-CCO Library!
P350 Perceptions of faecal microbiota transplantation in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P350: Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progression
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P350: Endoscopic sedation in IBD patients: a propensity score-matched retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P350: Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P350: Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P350: SAFIIR: Study of Anemia Following Intravenous Iron Repletion
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P350: The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P351 Spontaneous intra-abdominal abscesses in Crohn’s disease: The experience of a tertiary centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P351: Allogenic adipose-derived mesenchymal stem cells (darvadstrocel) in Japanese patients with complex perianal fistulas in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P351: Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P351: Do self-selected “Non-Transitioned” referrals from peadiatric services have lower treatment requirements?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P351: Faecal calprotectin correlates well with extent of active endoscopic inflammation in patients with ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P351: MRI outcomes in perianal fistulising Crohn’s disease following anti-TNF-α therapy: a systematic review and meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P351: SARS-CoV-2 infection and seroconversion in pediatric patients on biological therapy for Crohn’s disease: single tertiary center experience
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P351: Validation of anterior thigh ultrasound for screening of sarcopenia and elevated body fat in Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P352 Infliximab-therapy intensification based on endoscopic activity suppresses treatment interruption among patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P352: A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn’s disease. The Cross Pennine study II
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P352: Assessment of the use of therapeutic drug monitoring of Adalimumab during maintenance therapy in children with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P352: Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study group
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM